Matthew M Gubin

17PUBLICATIONS
138CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 13, 2026
Antigen presentation requirements for effective cDC1-based cancer immunotherapy.

|May 12, 2026
Immune microenvironment and strategy of immunotherapy in acral melanoma.

|Feb 23, 2026
Spatial immune hubs defined by conserved activated dendritic cells are remodeled by immunotherapy.

Tomoyuki Minowa, Sunita Keshari, Shan He

|Feb 09, 2026
Antigen presentation requirements for effective cDC1-based cancer immunotherapy.

Josué E Pineda, Tomoyuki Minowa, Li Shen

|Jan 19, 2026
Radionuclide-stimulated dynamic therapy induces complementary immunogenic necroptosis and apoptosis cancer cell death pathways.

Christopher Egbulefu, Kvar Black, Xinming Su

|Jan 09, 2026
Macrophage-Dendritic Cell-T-Cell Tetrads Orchestrate Antitumor Immunity and Response to Checkpoint Blockade.

Mehdi Chaib, Muhammad Aminu, Shelley Herbrich

Pageof 3

Frequent Collaborators

6 joint publications

Josué E Pineda

6 joint publications

Ken Chen

6 joint publications

Stephanie Watowich

5 joint publications

Sunita Keshari